Emergent BioSolutions (EBS) Operating Expenses (2011 - 2026)
Emergent BioSolutions (EBS) posted quarterly Operating Expenses of $145.6 million for Q1 2026, down 15.5% year-over-year from $172.3 million in Q1 2025, and down 17.55% quarter-over-quarter from $176.6 million in Q4 2025.
Emergent BioSolutions (EBS) Operating Expenses (2011 - 2026) Analysis & Trends
Emergent BioSolutions' Operating Expenses history runs 16 years deep, the most recent figure standing at $145.6 million for Q1 2026.
- In Q1 2026, Operating Expenses fell 15.5% year-over-year to $145.6 million; the TTM figure through Mar 2026 stood at $616.1 million (down 42.1% YoY), while the FY2025 annual figure was $642.8 million, down 44.22% from the prior year.
- Operating Expenses for Q1 2026 stood at $145.6 million, down from $176.6 million in the prior quarter.
- The five-year high for Operating Expenses was $630.8 million in Q2 2023, with the low at $139.3 million in Q2 2025.
- The 5-year median for Operating Expenses is $285.2 million (2022), against an average of $294.3 million.
- The sharpest annual moves came in 2023 and 2025: Operating Expenses soared 100.44% in 2023, then tumbled 69.6% in 2025.
- Emergent BioSolutions' Operating Expenses stood at $385.5 million in 2022, then dropped by 16.89% to $320.4 million in 2023, then plunged by 36.27% to $204.2 million in 2024, then decreased by 13.52% to $176.6 million in 2025, then slipped by 17.55% to $145.6 million in 2026.
- Business Quant data shows EBS's Operating Expenses at $145.6 million in Q1 2026, $176.6 million in Q4 2025, and $154.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Emergent BioSolutions | 251.81 Mn | 110.91 Mn | 137.20 Mn | 359.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 359.40 Mn |
| Mar 31, 2026 | 145.60 Mn |
| Dec 31, 2025 | 176.60 Mn |
| Sep 30, 2025 | 154.60 Mn |
| Jun 30, 2025 | 139.30 Mn |
| Mar 31, 2025 | 172.30 Mn |
| Dec 31, 2024 | 204.20 Mn |
| Sep 30, 2024 | 229.30 Mn |
| Jun 30, 2024 | 458.20 Mn |
| Mar 31, 2024 | 260.60 Mn |
| Dec 31, 2023 | 320.40 Mn |
| Sep 30, 2023 | 512.60 Mn |
| Jun 30, 2023 | 630.80 Mn |
| Mar 31, 2023 | 311.90 Mn |
| Dec 31, 2022 | 385.50 Mn |
| Sep 30, 2022 | 285.20 Mn |
| Jun 30, 2022 | 314.70 Mn |
| Mar 31, 2022 | 301.10 Mn |
| Dec 31, 2021 | 437.90 Mn |
| Sep 30, 2021 | 363.70 Mn |